top of page

​

Neurostar TMS

The Patient Health Questionnaire (PHQ-9) is a fast and simple way to assess your level of depression, and help determine if you may be suffering from a depressive disorder.

This questionnaire is not to be considered a medical diagnosis. After completing your questionnaire, please speak to a doctor near you or your physician to determine what steps may be best for you.

What is NeuroStar®?

TMS is Transcranial Magnetic Stimulation therapy, a non-drug treatment for major depression. TMS uses focused magnetic pulses, similar to an MRI, to reignite dormant synapses in the brain and help your brain function the way it was meant to.

​

It is not a drug, “shock” therapy, or surgery. It is a safe, effective treatment for MDD without the common side effects of medication.

Neurostar TMS treatment example
The depressed brain vs the brain treated with TMS

NeuroStar® TMS Works When Antidepressants Don’t

For patients who haven’t seen adequate relief from antidepressants, trying another medication isn’t always the answer. NeuroStar may be the best option: a non-drug depression treatment proven to transform lives. 

Mark George M.D. Biological Psychiatry Branch Division of Intramural Research Progress, NIMH 1993

How soon will you see results?

Many NeuroStar patients start to see improvement within 2 to 3 weeks of treatment. That can include changes in mood, fewer days of depression, and increased desire to engage with other people more often. In fact, your friends and family may notice your results before you do!

​

As with any therapy, completion is key. Completing the full 36 treatment course gives the best chance for delivering long-lasting relief from depression

Precision pulse delivered during TMS

Is Neurostar Effective?

NeuroStar Advanced TMS therapy is an outpatient treatment that takes as little as 19 minutes per session. A study of real-world outcomes reported an 83% response rate which means patients experienced notable relief, and a 62% remission rate which means their depression effectively went away.

​

The STAR*D study, the largest clinical trial of MDD ever conducted, showed that the rate of remission goes down with each new medication needed. If you’ve tried 3 or more medications, the chance of remission was just 7%.

Does TMS Hurt?

NeuroStar is not a drug, “shock” therapy, or surgery. And it doesn’t have any of the common side effects associated with traditional antidepressants.

​

There is no sedation, anesthesia, or recovery time and for most people the NeuroStar treatment is relaxing. The most common side effect is mild to moderate pain or discomfort at the treatment site that usually subsides within the first week of treatment.

Does Insurance Cover Neurostar TMS?

Unlike biofeedback and EMDR, Neurostar TMS is covered by most insurance carriers. To find out if your insurance will cover Neurostar TMS, contact our Layton or Pocatello offices.

Adult Indications for Use

The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

Adolescent Indications for Use

NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).

NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.

Important Safety Information

The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).

NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.

Learn More About TMS

bottom of page